长春高新：与丹麦ALK达成变应原特异性免疫治疗产品合作

Core Viewpoint - Changchun High-tech announced a collaboration with Danish company ALK-Abelló A/S to develop and commercialize allergen-specific immunotherapy (AIT) products for house dust mites (HDM) in China, gaining exclusive rights to three of ALK's independently developed products in mainland China [1] Group 1 - Changchun High-tech's subsidiary, Changchun Jinsai Pharmaceutical Co., Ltd., will work with ALK on the AIT products [1] - The collaboration focuses on the development and commercialization of HDM allergen-specific immunotherapy products in the Chinese market [1] - The agreement includes exclusive agency rights for three ALK-developed products within mainland China [1]